Status
Conditions
About
The aim of this study is to evaluate inflammatory response as a prognostic factor of atrial fibrillation recurrency after ablation. Inflammatory response will be assessed by double measurement of C-reactive protein, fibroblast growth factor 2 (FGF2), matrix metallopeptidase 8 (MMP8) and body temperature. Dynamics of change of troponin I will be measured additionally.
After ablation each patient will be monitored with ECG telemonitoring system for 7 days.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Krzysztof Ozierański, MD; Michał Peller, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal